ASKER CONTRACT MANUFACTURING AS

Operating

Produktutvikling, produksjon og forsyningsdistribusjon av tyggbare kalsium- og vitamin D3-tabletter og annen tilsvarende virksomhet, samt alt som står i forbindelse med dette.

Produksjon, forsyningsdistribusjon og produktutvikling av farmasøytiske produkter, herunder tyggbare kalsium- og vitamin D3-tabletter.

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

CEO: BL
Bjørn Lie1963
Chairman of the board: EC
Eric Carsten Schmidhäuser1969
Years since formation: 4 years; since Apr 27, 2022
Type: Limited company
VAT registered: Yes
Number of employees: 153

Ownership

Number of shares and share classes: 30,000; 1 share class
Total number of shareholders: 1; person

Financials

Total operating income 2025: 492,211,504; NOK
Annual total result 2025: 38,658,086; NOK
Total equity 2025: 569,599,393; NOK

Last update: Jul 15, 2026

Management

Management / administration

Name	Role	Shares
BL Bjørn Lie 1963	Managing Director/CEO	-

Board

Name	Role	Shares
EC Eric Carsten Schmidhäuser 1969	Chairman	-
WM William Mark Hawkins 1972	Board Member	-
PS Petter Sørensen 1968	Alternate Member	-
SR Sven Rune Andersen 1982	Board Member	-
CH Clara Hallén 1981	Alternate Member	-
KA Kristine Arnestad Næss 1972	Alternate Member	-
VH Veronica Horpestad Liane 1978	Board Member	-
KB Kjetil Buer 1970	Alternate Member	-
KT Kjell Tore Lied Steiro 1978	Alternate Member	-
GS Gabriele Strikauskaite 1985	Alternate Member	-

Others

Name	Role	Shares
K KPMG AS	Auditor	-

Last update: Jun 27, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
NG Nextpharma Germany Bidco Gmbh	Ordinary shares	30,000	100 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2025	2024	2023	2022
Total operating income	492,211,504	505,501,857	468,184,551	0
Annual Total Result	38,658,086	35,277,828	53,817,067	0
Total assets	646,146,642	592,997,927	593,240,537	30,000
Total liabilities	76,547,249	62,056,620	97,577,059	0
Total equity	569,599,393	530,941,307	495,663,479	30,000

P&L

Year	2025	2024	2023
Total operating income	492,211,504	505,501,857	468,184,551
Total operating costs	451,972,199	466,629,811	395,925,014
Operating result	40,239,305	38,872,046	72,259,536
Financial income/costs	8,893,627	6,279,090	-3,263,296
Profit before tax	49,132,932	45,151,136	68,996,240
Total tax & extraordinary income/cost	10,474,846	9,873,308	15,179,173
Annual Total Result	38,658,086	35,277,828	53,817,067

Balance overview

Year	2025	2024	2023	2022
Total fixed assets	288,462,666	303,987,410	310,291,473	0
Total current assets	357,683,976	289,010,517	282,949,064	30,000
Total assets	646,146,642	592,997,927	593,240,537	30,000
Short term debt	76,547,249	62,056,620	97,577,059	0
Long term debt	0	0	0	0
Total liabilities	76,547,249	62,056,620	97,577,059	0
Contributed capital	441,846,412	441,846,411	441,846,411	30,000
Retained earnings	127,752,981	89,094,895	53,817,067	0
Total equity	569,599,393	530,941,307	495,663,479	30,000
Total equity and liabilities	646,146,642	592,997,927	593,240,537	30,000

Classification

21st company classification

BETA

Industrial large enterprise

ASKER CONTRACT MANUFACTURING AS929 107 187